Advertisement

World Journal of Surgery

, Volume 35, Issue 8, pp 1732–1737 | Cite as

A Primer on a Hepatocellular Carcinoma Bioresource Bank Using the Cancer Genome Atlas Guidelines: Practical Issues and Pitfalls

  • N. Thao T. Nguyen
  • Ron T. Cotton
  • Theresa R. Harring
  • Jacfranz J. Guiteau
  • Marie-Claude Gingras
  • David A. Wheeler
  • Christine A. O’Mahony
  • Richard A. Gibbs
  • F. Charles Brunicardi
  • John A. GossEmail author
Article

Abstract

Background

Since the advent of the human genome, the era of personalized genomic medicine is indisputably in progress.

Methods

In an effort to contribute to the evolving knowledge of genomic medicine, we have aimed directly at building a bioresource bank for hepatocellular carcinoma. This tumor bank is based on the rigorous guidelines set forth by the National Cancer Institute, and it offers analytes to help elucidate the mechanisms of progression from cirrhosis to malignancy, risk factors for recurrence, and applicability of current treatment options to a diverse group of people.

Conclusions

Surgeons have a privileged position between patients (and their cancer) and the benches of basic science. Thus, we offer a primer based on our own experiences, from which surgeons may take elements to build their own bioresource bank for use in collaboration with others. We highlight some practicalities and pitfalls that could be overlooked, as well as a discussion of possible solutions.

Keywords

Tace Tissue Bank Comprehensive Cancer Center Common Data Element Cryogenic Vial 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgments

The authors are grateful to the members of the Human Genome Sequencing Center, who helped to make this manuscript, not the least of which is the Bioinformatics division. We are thankful for the dedication, expertise and support of Drs. Dolores Lopez-Terrada and Milton Finegold of the Department of Pathology at Baylor College of Medicine. Special thanks are owed to the Liver Center, the Hepatobiliary faculty, and all the residents at the Michael E. DeBakey Department of General Surgery, who tirelessly care for our patients. And, of course, we are grateful to our patients, without whom this research could not exist and whose sacrifices will not be taken for granted. This study was supported in part by grants from National Institutes of Health (NIH) U54-HG003273, U54-HG004973 (to R.A.G.); and Cancer Prevention & Research Institution of Texas (CPRIT) grant RP101353-P01/P07 (also to R.A.G.).

References

  1. 1.
    El-Serag HB, Rudolph KL (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132:2557–2576PubMedCrossRefGoogle Scholar
  2. 2.
    Abrams P, Marsh JW (2010) Current approach to hepatocellular carcinoma. Surg Clin North Am 90:803–816PubMedCrossRefGoogle Scholar
  3. 3.
    Colak D, Chishti MA, Al-Bakheet AB et al (2010) Integrative and comparative genomics analysis of early hepatocellular carcinoma differentiated from liver regeneration in young and old. Mol Cancer 9:146PubMedCrossRefGoogle Scholar
  4. 4.
    Goebell PJ, Marente MM (2010) New concepts of biobanks—strategic chance for uro-oncology. Urol Oncol 28:449–457PubMedCrossRefGoogle Scholar
  5. 5.
    Clement B, Chene G, Degos F (2009) A national collection of liver tumours: lessons learnt from 6 years of biobanking in France. Cancer Lett 286:140–144PubMedCrossRefGoogle Scholar
  6. 6.
    Hwang RF, Wang H, Lara A et al (2008) Development of an integrated biospecimen bank and multidisciplinary clinical database for pancreatic cancer. Ann Surg Oncol 15:1356–1366PubMedCrossRefGoogle Scholar
  7. 7.
    ISBER (2008) Best practices for repositories. Cell Preserv Technol. Available at http://www.isber.org/ibc.html. Accessed December 30, 2010
  8. 8.
    Voidonikolas G, Gingras MC, Hodges S et al (2009) Developing a tissue resource to characterize the genome of pancreatic cancer. World J Surg 33:723–731PubMedCrossRefGoogle Scholar
  9. 9.
    Voidonikolas G, Kreml SS, Chen C et al (2009) Basic principles and technologies for deciphering the genetic map of cancer. World J Surg 33:615–629PubMedCrossRefGoogle Scholar
  10. 10.
    Riegman PHJ, deJong BWD, Llombart-Bosch A (2010) The organization of European Cancer Institute Pathobiology Working Group and its support of European biobanking infrastructures for translational cancer research. Cancer Epidemiol Biomarkers Prev 19:923–926PubMedCrossRefGoogle Scholar
  11. 11.
    Blow N (2007) The personal side of genomics. Nature 449:627–630PubMedCrossRefGoogle Scholar
  12. 12.
    Wheeler DA, Srinivasan M, Egholm M et al (2008) The complete genome of an individual by massively parallel DNA sequencing. Nature 452:872–877PubMedCrossRefGoogle Scholar
  13. 13.
    Office of Biorepositories and Biospecimen Research. Available at http://biospecimens.cancer.gov/default.asp. Accessed October 15, 2010
  14. 14.
    The Cancer Human Biobank. Available at http://cahub.cancer.gov/. Accessed October 15, 2010
  15. 15.
    NCI Best Practices for Biospecimen Resources (Office of Biorepositories and Biospecimen Research, NCI, NIH, US DHHS, 2010)Google Scholar
  16. 16.
    Vaught JB, Caboux E, Hainaut P (2010) International efforts to develop biospecimen best practices. Cancer Epidemiol Biomarkers Prev 19:912–915PubMedCrossRefGoogle Scholar
  17. 17.
    Barnes R, Parisien M, Murphy LC et al (2008) Influence of evolution in tumor biobanking on the interpretation of translational research. Cancer Epidemiol Biomarkers Prev 17:3344–3350PubMedCrossRefGoogle Scholar
  18. 18.
    Riegman HJP, Morente MM, Betsou F et al (2008) Biobanking for better healthcare. Mol Oncol 2:213–222PubMedCrossRefGoogle Scholar
  19. 19.
    Cambon-Thomsen A, Ducournau P, Gourraud PA et al (2003) Biobanks for genomics and genomics for biobanks. Comp Funct Genomics 4:628–634PubMedCrossRefGoogle Scholar
  20. 20.
    Knoppers BM (2005) Biobanking: international norms. Regulation of biobanks. J Law Med Ethics 33(Spring):7–14Google Scholar
  21. 21.
    Hall MA, King NMP, Perdue LH et al (2010) Biobanking, consent and commercialization in international genetics research: the Type 1 Diabetes Genetics Consortium. Clin Trials 7:S33–S45PubMedCrossRefGoogle Scholar
  22. 22.
    Ursin LO (2010) Privacy and property in the biobank context. HEC Forum 22:211–224PubMedCrossRefGoogle Scholar
  23. 23.
    Moore HM, Comptom CC, Lim MD et al (2009) Biospecimen research network symposium: advancing cancer research through biospecimen science. Cancer Res 69:6770–6772PubMedCrossRefGoogle Scholar
  24. 24.
    MacLeod AK, Liewald DCM, McGilchrist MM et al (2009) Some principles and practices of genetic biobanking studies. Eur Respir J 33:419–425PubMedCrossRefGoogle Scholar
  25. 25.
    Psyrri A, Licitra L, Lacombe D et al (2010) Strategies to promote translational research within the European Organisation for Research and Treatment of Cancer (EORTC) Head and Neck Cancer Group: a report from the Translational Research Committee. Ann Oncol 21:1952–1960PubMedCrossRefGoogle Scholar

Copyright information

© Société Internationale de Chirurgie 2011

Authors and Affiliations

  • N. Thao T. Nguyen
    • 1
  • Ron T. Cotton
    • 1
  • Theresa R. Harring
    • 1
  • Jacfranz J. Guiteau
    • 1
  • Marie-Claude Gingras
    • 2
  • David A. Wheeler
    • 2
  • Christine A. O’Mahony
    • 1
    • 3
  • Richard A. Gibbs
    • 2
  • F. Charles Brunicardi
    • 1
  • John A. Goss
    • 1
    • 3
    Email author
  1. 1.Michael E. DeBakey Department of SurgeryBaylor College of MedicineHoustonUSA
  2. 2.Department of Molecular and Human Genetics, Human Genome Sequencing CenterBaylor College of MedicineHoustonUSA
  3. 3.The Liver Center, Division of Abdominal Transplantation & Hepatobiliary Surgery, Michael E. DeBakey Department of SurgeryBaylor College of MedicineHoustonUSA

Personalised recommendations